Fundraising FoxCriteria Bio Ventures — Full Portfolio
20 tracked investments · listed companies and verified rows first
AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases.
BiotechHealthtech
Ignacio Anegon(Co-founder, Senior Consultant & SAB Member)inCarole Guillonneau(Co-founder & Head of Research)inFrançois-Xavier Hubert(Co-founder, Past President & Board Member)
Co-investorsNewton BiocapitalSound BioventuresSambrinvestWallonie Entreprendre
Adaptam Therapeutics develops antibody-based cancer immunotherapies, including antibody-drug conjugates and bispecific antibodies, that target the immunosuppressive myeloid tumor microenvironment via novel targets such as glycan-binding proteins and Siglecs.
BiotechHealthtechSan Sebastián, ES
Asis Palazon(CEO/CSO & Founder)in
NRG Therapeutics is a biotech company developing small-molecule drugs targeting the mitochondrial permeability transition pore (mPTP) for neurodegenerative diseases such as ALS and Parkinson's.
BiotechHealthtechLongevity
Neil Miller(CEO)inRichard Rutter(CSO)inGrant Hawthorne(COO)inClaus Sundgreen(Chief Medical Officer)inPaul Thompson(CDO)in
BoardJonathan Savidge(Independent Non Executive Chair)
Co-investorsBrandon CapitalNovartis Venture FundSV Health InvestorsBritish Business BankM VenturesDementia Discovery Fund+1 more
AELIX Therapeutics is a company developing a therapeutic HIV vaccine intended for use in HIV cure and eradication strategies.
BiotechHealthtechBarcelona, ES
Co-investorsYsios Capital
aptaTargets develops aptamer-based therapeutics and diagnostics for cerebrovascular diseases, with a lead program (ApTOLL) targeting stroke treatment.
AI & Machine LearningBiotechHealthtechMedical DevicesMadrid, ES
David(Co-Founder & CEO)Maria Eugenia(Co-Founder & CFO)in
Co-investorsInveready Technology Investment Group
Circe Scientific provides DMPK (drug metabolism and pharmacokinetics) and PK/PD consulting for biotech, pharmaceutical, and venture capital clients working in drug discovery and development.
AgTechBiotechHealthtechLongevityWellness & FitnessMallorca, ES
Fernando BarreraDr. Rafel Prohens
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.
BiotechHealthtech
Co-investorsLifeArc VenturesMedical Incubator Japan K.K.Modi VenturesPathway BioventuresSound Bioventures4BIO Capital+1 more
Devicare sells nutritional and health products, including supplements and monitoring devices for conditions such as kidney stones and urinary infections.
ConsumerHealthtechWellness & Fitness
Co-investorsCapital CellEmesa Corporación EmpresarialShip2BAbac Capital Manager S.G.E.I.C.,European Investment Fund
InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients.
BiotechDigital HealthMedical Devices
BoardProf Rob E. Coleman(Chairman)
Co-investorsAsabys PartnersYsios CapitalAlta Life Sciences
Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.
BiotechDeep TechHealthtechMedical DevicesMataró, ES
Marc Martinell(Co-Founder & Chief Executive Officer)in
Co-investorsChiesi VenturesFund+Invivo Capital PartnersKurma PartnersRoche Venture FundYsios Capital+5 more
Nuubo offers a wireless, non-invasive cardiac monitoring technology (aECG) based on textile electrodes for medium- and long-term remote heart monitoring.
Digital HealthHardwareMedical Devices
Co-investorsBAMCAPCapital CellFides Capital
CSL is a biotechnology company that develops and manufactures plasma-derived and other therapies, including biotherapies for rare and serious diseases, vaccines, and treatments for iron deficiency and kidney disease.
BiotechHealthtechMedical Devices
Joan Perello Bestard(Founder)inCris Calsadain
Co-investorsAndera PartnersColumbus Venture PartnersInvivo Capital PartnersYsios Capital
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)Miquel Vila-Perelló, Ph.D(Co-Founder & CEO)Silvia Frutos, Ph.D(Co-Founder & CTO)
Co-investorsAsabys PartnersNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalNew Enterprise Associates (NEA)+3 more
Tolerance is a compliance platform that runs continuous automated checks against the NIST 800-171 standard and collects assessor-ready evidence for teams handling Controlled Unclassified Information (CUI).
CybersecurityGovTechSaaS
Co-investorsDorm RoomAmadeus Capital PartnersBen Franklin Technology PartnersBioAdvanceColumbus Venture PartnersEast Innovate+5 more
Tolerance Bio develops therapeutics targeting the thymus—the regulator of immune tolerance—to preserve, restore, and manipulate its function and extend health span.
BiotechDeep TechLongevityPhiladelphia, US
Francisco Leon(Executive Officer, Director)inPhilip Ball(Executive Officer, Director)Justin Vogel(Executive Officer, Director)in
BoardDamia Tormo Carulla(Director)Pablo Cironi(Director)inRobert Goldstein(Director)
Co-investorsBioAdvanceBen Franklin Technology PartnersColumbus Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
6a341b14a0269d64dd34ca59 verifiedMosaic BiomedicalsNorthern Biologicsplay acWooptix
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.